Tuesday, December 7, 2021
HomeNewsProneuron's Phase II Study of ProCord

Proneuron’s Phase II Study of ProCord

| Source: proneuron.com

The Mount Sinai Medical Center and Kessler Institute for Rehabilitation Are Now Enrolling for Proneuron’s Phase II Study of ProCord for Neurologically Complete Spinal Cord Injury

Announcement Made at the Rally for the Cure in NYC

The Mount Sinai Medical Center (NYC) and Kessler Institute for Rehabilitation (West Orange, NJ) are now enrolling for Proneuron’s Phase II trial of ProCord, for complete spinal cord injury. The official announcement was made at the Rally For the Cure, at the Winter Garden Financial Center in New York City.

“This collaborative effort between leading centers of care for persons who have sustained a spinal cord injury is a testimony to the importance of how ‘working together we can make things happen’. This is the message for all professionals involved in the care of spinal cord injury,” said Dr. Steven Kirshblum, Principal Investigator and Director of Spinal Cord Injury Service, Kessler Institute for Rehabilitation.

Patients found eligible for the study will be randomly assigned to either a treatment or control group. Patients in the control group will not receive the study treatment. All control and treatment patients will receive standard spinal cord injury care and rehabilitation and will receive follow-up testing for one year.

“We selected this venue to jointly announce the launch of this trial at our centers to draw attention to the importance of collaboration if we are to be successful. We need everyone to spread the word to doctors, family and friends so that we can reach people in the crucial first few days after their injury,” said Dr. Kristjan Ragnarsson, the Principal Investigator and head of the Department of Rehabilitation Medicine at Mount Sinai.

This international, multi-center, randomized-controlled, experimental study is open to patients who meet eligibility criteria, including but not limited to an ASIA Grade A injury between C5-T11 Vertebrae, within 14 days of injury. Asia Grade A is defined as patients who have no feeling or movement below the point of injury.

Patient, Immediate Family of Patient and/or Physician inquiries:

24 hour a day Patient Recruitment Center:

Email: clinical.trial@proneuron.com

Telephone: 1 866 539 0767 (U.S. toll free) or 1 506 652 3486.

Fax: 1 866-214-7078

– Callers outside of the U.S., please use standard international dialing code

For additional information: www.proneuron.com

In addition to Kessler Institute for Rehabilitation and The Mount Sinai Medical Center, patients can be enrolled in the trial at Craig Hospital in Denver, Colorado, Principal Investigator, Dr. Daniel P. Lammertse and Sheba Medical Center in Israel, Principal Investigator, Dr. Nachshon Knoller. Shepherd Center in Atlanta, GA, Principal Investigator, Dr. David Apple, is also anticipated to begin enrollment in 2004 and is already taking an active role in the study.

About The Mount Sinai Medical Center

The Mount Sinai Medical Center includes The Mount Sinai Hospital, one of the country’s finest teaching hospitals, and Mount Sinai School of Medicine, internationally recognized for ground-breaking research, and innovative approaches to medical education. The Mount Sinai Department of Rehabilitation Medicine is a center of excellence in the delivery of complete care for people with disabilities and is consistently ranked among the best in the nation in surveys, such as US News & World Report’s best hospital issue. It is designated by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education as one of the nation’s 16 Spinal Cord Injury Model Systems of Care. A wide range of comprehensive medical and rehabilitation services is available for individuals with spinal cord injuries, brain injuries, and a variety of other neuromuscular, musculosketetal, and chronic conditions.

About Kessler Institute for Rehabilitation

For over 55 years, Kessler has pioneered the course of physical medicine and rehabilitation. Today, Kessler Institute for Rehabilitation, a Select Medical company, continues to lead this field through its comprehensive, medically-based rehabilitation programs in spinal cord injury, brain injury, stroke, amputation and orthopedic, neuromuscular and musculoskeletal disorders. In fact, Kessler is one of only 16 centers(1) in the country to be designated as a model system for the treatment and research of spinal cord injury. With four hospital centers located in West Orange, East Orange, Saddle Brook and Chester, NJ, Kessler is internationally recognized for its innovative treatment, quality of care, research and education programs. Kessler is also consistently listed among the nation’s best rehabilitation hospitals and the top such centers in the east by U.S. News & World Report.

(1) Kessler, the University of Medicine and Dentistry of New Jersey-NJ Medical School and Kessler Medical Rehabilitation Research and Education Corporation, comprise the Northern New Jersey Spinal Cord Injury System.

mailto:Marjie.hadad@proneuron.com
Proneuron
Marjie Hadad, +972-55-365-220
(Media Liaison)
Marjie.hadad@proneuron.com
or
Mount Sinai School of Medicine
Debra Kaplan, 212-659-9045
(Associate Director of External Relations)
debra.kaplan@mssm.edu
or
Kessler Institute for Rehabilitation
Gail Solomon, 973-243-6879
(Director of Corporate Communications)
pager 973-705-6813
gsolomon@kessler-rehab.com

- Advertisment -

Must Read

Today is the Day! Let’s Break the #ATWorldRecord Together!

Have you ever been part of a world record? Now’s your chance. We’re under way on our #ATWorldRecord attempt! We need your help TODAY...